ReP USP - Resultado da busca

Artigo de periodico
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria (2025)
Kulasekararaj, Austin; Brodsky, Robert; Schrezenmeier, Hubert; Griffin, Morag; Roeth, Alexander; Piatek, Caroline; Ogawa, Masayo; Yu, Ji; Patel, Ami S; Gualandro, Sandra Fátima Menosi
Fonte: Annals of hematology. Unidade: FM
Assuntos: FÁRMACOS IMUNOSSUPRESSORES, SOBREVIDA, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KULASEKARARAJ, Austin et al. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of hematology, v. 104, n. 1, p. 81-94, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84810. Acesso em: 23 nov. 2025.
APA
Kulasekararaj, A., Brodsky, R., Schrezenmeier, H., Griffin, M., Roeth, A., Piatek, C., et al. (2025). Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of hematology, 104( 1), 81-94. doi:10.1007/s00277-025-06193-5
NLM
Kulasekararaj A, Brodsky R, Schrezenmeier H, Griffin M, Roeth A, Piatek C, Ogawa M, Yu J, Patel AS, Gualandro SFM. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria [Internet]. Annals of hematology. 2025 ; 104( 1): 81-94.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84810
Vancouver
Kulasekararaj A, Brodsky R, Schrezenmeier H, Griffin M, Roeth A, Piatek C, Ogawa M, Yu J, Patel AS, Gualandro SFM. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria [Internet]. Annals of hematology. 2025 ; 104( 1): 81-94.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84810
Artigo de periodico
Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia (2024)
Perruso, Luiza Lapolla; Velloso, Elvira Deolinda Rodrigues Pereira ; Rocha, Vanderson Geraldo ; Rego, Eduardo Magalhães ; Silva, Wellington Fernandes
Fonte: Annals of hematology. Unidade: FM
Assuntos: LEUCEMIA, SISTEMA NERVOSO CENTRAL, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERRUSO, Luiza Lapolla et al. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia. Annals of hematology, v. 103, n. 6, p. 2033-2039, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76787. Acesso em: 23 nov. 2025.
APA
Perruso, L. L., Velloso, E. D. R. P., Rocha, V. G., Rego, E. M., & Silva, W. F. (2024). Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia. Annals of hematology, 103( 6), 2033-2039. doi:10.1007/s00277-023-05609-4
NLM
Perruso LL, Velloso EDRP, Rocha VG, Rego EM, Silva WF. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia [Internet]. Annals of hematology. 2024 ; 103( 6): 2033-2039.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76787
Vancouver
Perruso LL, Velloso EDRP, Rocha VG, Rego EM, Silva WF. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia [Internet]. Annals of hematology. 2024 ; 103( 6): 2033-2039.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76787
Artigo de periodico
Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response (2023)
Ferreira, Amanda Pifano Soares; Seguro, Fernanda Salles; Abdo, Andre Ramires Neder; Santos, Fernanda Maria; Maciel, Felipe Vieira Rodrigues; Nardinelli, Luciana; Giorgi, Ricardo Rodrigues; Ruiz, Antonio Roberto Lancha; Rego, Eduardo Magalhães ; Rocha, Vanderson Geraldo
Fonte: Annals of hematology. Unidade: FM
Assuntos: DOENÇA CRÔNICA, LEUCEMIA MIELOIDE, SOBREVIDA, ESTUDOS MULTICÊNTRICOS, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Amanda Pifano Soares et al. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response. Annals of hematology, v. 102, n. 7, p. 1761-1771, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54584. Acesso em: 23 nov. 2025.
APA
Ferreira, A. P. S., Seguro, F. S., Abdo, A. R. N., Santos, F. M., Maciel, F. V. R., Nardinelli, L., et al. (2023). Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response. Annals of hematology, 102( 7), 1761-1771. doi:10.1007/s00277-023-05189-3
NLM
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Rego EM, Rocha VG. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response [Internet]. Annals of hematology. 2023 ; 102( 7): 1761-1771.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54584
Vancouver
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Rego EM, Rocha VG. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response [Internet]. Annals of hematology. 2023 ; 102( 7): 1761-1771.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54584
Artigo de periodico
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting (2022)
Mendes, Fernanda Rodrigues; Silva, Wellington Fernandes da; Melo, Raphael da Costa Bandeira de; Silveira, Douglas Rafaele Almeida; Velloso, Elvira Deolinda Rodrigues Pereira ; Rocha, Vanderson Geraldo ; Rego, Eduardo Magalhães
Fonte: Annals of hematology. Unidade: FM
Assuntos: LEUCEMIA MIELOIDE AGUDA, MORTALIDADE, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDES, Fernanda Rodrigues et al. Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting. Annals of hematology, v. 101, n. 1, p. 147-154, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00277-021-04687-6. Acesso em: 23 nov. 2025.
APA
Mendes, F. R., Silva, W. F. da, Melo, R. da C. B. de, Silveira, D. R. A., Velloso, E. D. R. P., Rocha, V. G., & Rego, E. M. (2022). Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting. Annals of hematology, 101( 1), 147-154. doi:10.1007/s00277-021-04687-6
NLM
Mendes FR, Silva WF da, Melo R da CB de, Silveira DRA, Velloso EDRP, Rocha VG, Rego EM. Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting [Internet]. Annals of hematology. 2022 ; 101( 1): 147-154.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00277-021-04687-6
Vancouver
Mendes FR, Silva WF da, Melo R da CB de, Silveira DRA, Velloso EDRP, Rocha VG, Rego EM. Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting [Internet]. Annals of hematology. 2022 ; 101( 1): 147-154.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00277-021-04687-6
Artigo de periodico
Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia (2022)
Saldanha, Artur; Orsi, Fernanda A. ; Okazaki, Erica; Rothschild, Cynthia; Prestes, Paula; Stefanello, Bianca; Alves, Lucas; Rocha, Vanderson; Villaca, Paula
Fonte: Annals of hematology. Unidade: FM
Assuntos: TROMBOCITOPENIA, SEGURANÇA DO PACIENTE, ESPLENECTOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALDANHA, Artur et al. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia. Annals of hematology, v. 101, n. 12, p. 2781-2784, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50396. Acesso em: 23 nov. 2025.
APA
Saldanha, A., Orsi, F. A., Okazaki, E., Rothschild, C., Prestes, P., Stefanello, B., et al. (2022). Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia. Annals of hematology, 101( 12), 2781-2784. doi:10.1007/s00277-022-04985-7
NLM
Saldanha A, Orsi FA, Okazaki E, Rothschild C, Prestes P, Stefanello B, Alves L, Rocha V, Villaca P. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia [Internet]. Annals of hematology. 2022 ; 101( 12): 2781-2784.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50396
Vancouver
Saldanha A, Orsi FA, Okazaki E, Rothschild C, Prestes P, Stefanello B, Alves L, Rocha V, Villaca P. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia [Internet]. Annals of hematology. 2022 ; 101( 12): 2781-2784.[citado 2025 nov. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50396
Artigo de periodico
Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma (2019)
Lage, Luis Alberto de Padua Covas; Hamasaki, Debora Toshie; Moreira, Frederico Rafael; Rocha, Vanderson Geraldo ; Zerbini, Maria Claudia Nogueira ; Pereira, Juliana
Fonte: Annals of hematology. Unidade: FM
Assuntos: MONÓCITOS, LINFOMA, LINFÓCITOS, SOBREVIDA, MACRÓFAGOS, PROGNÓSTICO, CONTAGEM DE CÉLULAS SANGUÍNEAS, BIÓPSIA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAGE, Luis Alberto de Padua Covas et al. Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma. Annals of hematology, v. 98, n. 9, p. 2097-2102, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00277-019-03731-w. Acesso em: 23 nov. 2025.
APA
Lage, L. A. de P. C., Hamasaki, D. T., Moreira, F. R., Rocha, V. G., Zerbini, M. C. N., & Pereira, J. (2019). Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma. Annals of hematology, 98( 9), 2097-2102. doi:10.1007/s00277-019-03731-w
NLM
Lage LA de PC, Hamasaki DT, Moreira FR, Rocha VG, Zerbini MCN, Pereira J. Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma [Internet]. Annals of hematology. 2019 ; 98( 9): 2097-2102.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00277-019-03731-w
Vancouver
Lage LA de PC, Hamasaki DT, Moreira FR, Rocha VG, Zerbini MCN, Pereira J. Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma [Internet]. Annals of hematology. 2019 ; 98( 9): 2097-2102.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00277-019-03731-w
Artigo de periodico
Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation (2018)
Buccheri, Valeria; Barreto, Wolney Gois; Fogliatto, Laura Maria; Capra, Marcelo; Marchiani, Mariana; Rocha, Vanderson Geraldo
Fonte: Annals of hematology. Unidade: FM
Assuntos: LEUCEMIA, DOENÇAS LINFÁTICAS, PROGNÓSTICO, CROMOSSOMOS HUMANOS, MUTAÇÃO, DELEÇÃO DE GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUCCHERI, Valeria et al. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Annals of hematology, v. 97, n. 12, p. 2269-2278, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00277-018-3503-6. Acesso em: 23 nov. 2025.
APA
Buccheri, V., Barreto, W. G., Fogliatto, L. M., Capra, M., Marchiani, M., & Rocha, V. G. (2018). Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Annals of hematology, 97( 12), 2269-2278. doi:10.1007/s00277-018-3503-6
NLM
Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M, Rocha VG. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation [Internet]. Annals of hematology. 2018 ; 97( 12): 2269-2278.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00277-018-3503-6
Vancouver
Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M, Rocha VG. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation [Internet]. Annals of hematology. 2018 ; 97( 12): 2269-2278.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00277-018-3503-6

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos